Viatris Inc. (VTRS)
Nasdaq: VTRS · Pharmaceutical Preparations · Canonsburg, PA · filing with the SEC since 2019
Who owns Viatris Inc.
As filed with the SECHolders of 5% or more
5
Fmr LLC holds 11% of COMMON STOCK, as its SCHEDULE 13G/A filed Sep 8, 2026 says.
Directors and officers
18
report now, of 34 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Fmr LLC
SCHEDULE 13G/A · filed Sep 8, 2026 · COMMON STOCK · 8.3% in Aug 6, 2026
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
Blackrock, Inc.
SCHEDULE 13G/A · filed Oct 17, 2025 · Common Stock
Davis Selected Advisers
SCHEDULE 13G/A · filed Aug 12, 2026 · Common Stock · 6.8% in May 5, 2026
T. Rowe Price Associates, Inc.
SCHEDULE 13G · filed May 14, 2025 · COMMON STOCK
State Street Corporation
SCHEDULE 13G · filed Aug 11, 2025 · COMMON STOCK · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What VTRS reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Idorsia Pharmaceuticals Ltd.
A company bought · acquisition · Feb 2024 · owns, named in the 10-K filed Feb 26, 2026
Oyster Point Pharma Acquisition
A company bought · acquisition · owns, named in the 10-K filed Feb 26, 2026
280 subsidiaries in 59 countries, from the list filed with the 10-K filed Feb 26, 2026.
Insider tradesForm 4
2sales
1purchases
1sales on a scheduled plan
1people selling
$1.1Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 2, 2025 to Oct 2, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 2, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 35 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Campbell Paul | Interim Chief Financial Officer, Chief Accounting Officer and Corporate Controller | 2 | $1.1M | 1 | 0 | $0 |
| Simmons David S | director | 0 | $0 | 0 | 1 | $0 |